Molecular Testing of Serial Blood Specimens from Patients with Early Lyme Disease during Treatment Reveals Changing Coinfection with Mixtures of Borrelia burgdorferi Genotypes | Zendy

Michael R. Mosel | Zendy; Heather E. Carolan | Zendy; Alison W. Rebman | Zendy; Steven Castro | Zendy; Christian Massire | Zendy; David J. Ecker | Zendy; Mark J. Soloski | Zendy; John N. Aucott | Zendy; Mark W. Eshoo | Zendy

Open Access

Molecular Testing of Serial Blood Specimens from Patients with Early Lyme Disease during Treatment Reveals Changing Coinfection with Mixtures of Borrelia burgdorferi Genotypes

Author(s) -

Michael R. Mosel,

Heather E. Carolan,

Alison W. Rebman,

Steven Castro,

Christian Massire,

David J. Ecker,

Mark J. Soloski,

John N. Aucott,

Mark W. Eshoo

Publication year - 2019

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00237-19

Subject(s) - lyme disease , borrelia burgdorferi , coinfection , borrelia , spirochaetaceae , genotype , virology , biology , medicine , microbiology and biotechnology , immunology , human immunodeficiency virus (hiv) , antibody , genetics , gene

Borrelia burgdorferi is the etiological agent of Lyme disease. In the current study, we used direct-detection PCR and electrospray ionization mass spectrometry to monitor and genotypeB. burgdorferi isolates from serially collected whole-blood specimens from patients clinically diagnosed with early Lyme disease before and during 21 days of antibiotic therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research